Kim Engler

945 total citations · 1 hit paper
62 papers, 529 citations indexed

About

Kim Engler is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Kim Engler has authored 62 papers receiving a total of 529 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Infectious Diseases, 25 papers in Epidemiology and 20 papers in General Health Professions. Recurrent topics in Kim Engler's work include HIV/AIDS Research and Interventions (41 papers), HIV, Drug Use, Sexual Risk (18 papers) and HIV-related health complications and treatments (12 papers). Kim Engler is often cited by papers focused on HIV/AIDS Research and Interventions (41 papers), HIV, Drug Use, Sexual Risk (18 papers) and HIV-related health complications and treatments (12 papers). Kim Engler collaborates with scholars based in Canada, France and United Kingdom. Kim Engler's co-authors include Bertrand Lebouché, David Lessard, Yuanchao Ma, Moustafa Laymouna, Marina B. Klein, Tibor Schuster, Réjean Thomas, Joseph Cox, Kedar Mate and Joseph Josy Lévy and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and AIDS.

In The Last Decade

Kim Engler

56 papers receiving 519 citations

Hit Papers

Roles, Users, Benefits, and Limitations of Chatbots in He... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Engler Canada 11 265 205 158 74 63 62 529
Jamie P. Morano United States 15 282 1.1× 302 1.5× 177 1.1× 58 0.8× 92 1.5× 31 547
Nicky Perry United Kingdom 13 379 1.4× 275 1.3× 135 0.9× 81 1.1× 21 0.3× 39 542
Chi Linh Hoang Vietnam 13 158 0.6× 115 0.6× 108 0.7× 82 1.1× 23 0.4× 26 472
Ernest Ekong United States 14 498 1.9× 281 1.4× 151 1.0× 43 0.6× 99 1.6× 28 666
Lillian Lourenço Canada 14 479 1.8× 411 2.0× 110 0.7× 97 1.3× 93 1.5× 21 722
Soodabeh Navadeh Iran 15 234 0.9× 360 1.8× 114 0.7× 185 2.5× 47 0.7× 27 579
Sarah Robbins Scott China 10 153 0.6× 174 0.8× 62 0.4× 54 0.7× 50 0.8× 27 300
Nadine Kronfli Canada 18 345 1.3× 527 2.6× 154 1.0× 115 1.6× 365 5.8× 78 827
Alison Munro United Kingdom 17 225 0.8× 564 2.8× 149 0.9× 58 0.8× 261 4.1× 35 787
Julia Hidalgo United States 13 534 2.0× 376 1.8× 240 1.5× 84 1.1× 14 0.2× 28 724

Countries citing papers authored by Kim Engler

Since Specialization
Citations

This map shows the geographic impact of Kim Engler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Engler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Engler more than expected).

Fields of papers citing papers by Kim Engler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Engler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Engler. The network helps show where Kim Engler may publish in the future.

Co-authorship network of co-authors of Kim Engler

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Engler. A scholar is included among the top collaborators of Kim Engler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Engler. Kim Engler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lebouché, Bertrand, Dan Poenaru, Sofiane Achiche, et al.. (2025). Perspective on patient and non-academic partner engagement for the responsible integration of large language models in health chatbots. Research Involvement and Engagement. 11(1). 143–143.
3.
Laymouna, Moustafa, Yuanchao Ma, David Lessard, et al.. (2024). Needs-Assessment for an Artificial Intelligence-Based Chatbot for Pharmacists in HIV Care: Results from a Knowledge–Attitudes–Practices Survey. Healthcare. 12(16). 1661–1661. 1 indexed citations
5.
Laymouna, Moustafa, Yuanchao Ma, David Lessard, et al.. (2024). Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review. Journal of Medical Internet Research. 26. e56930–e56930. 73 indexed citations breakdown →
7.
Ma, Yuanchao, Sofiane Achiche, David Lessard, et al.. (2024). The first AI‐based Chatbot to promote HIV self‐management: A mixed methods usability study. HIV Medicine. 26(2). 184–206. 6 indexed citations
9.
Mate, Kedar, Kim Engler, David Lessard, & Bertrand Lebouché. (2023). Barriers to adherence to antiretroviral therapy: identifying priority areas for people with HIV and healthcare professionals. International Journal of STD & AIDS. 34(10). 677–686. 7 indexed citations
10.
Ma, Yuanchao, David Lessard, Kim Engler, et al.. (2023). An Artificial Intelligence-Based Chatbot to Promote HIV Primary Care Self-Management: a Mixed Method Usability Study. PolyPublie (École Polytechnique de Montréal). 5267–5267. 2 indexed citations
11.
Lessard, David, Kim Engler, Yuanchao Ma, et al.. (2022). Remote Follow-up of Self-isolating Patients With COVID-19 Using a Patient Portal: Protocol for a Mixed Methods Pilot Study (Opal-COVID Study). JMIR Research Protocols. 11(8). e35760–e35760.
12.
Arora, Anish, Kim Engler, David Lessard, et al.. (2022). Experiences of Migrant People Living with HIV in a Multidisciplinary HIV Care Setting with Rapid B/F/TAF Initiation and Cost-Covered Treatment: The ‘ASAP’ Study. Journal of Personalized Medicine. 12(9). 1497–1497. 7 indexed citations
13.
Mate, Kedar, Kim Engler, Marie‐Pascale Pomey, et al.. (2021). Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review. JMIR mhealth and uhealth. 9(4). e24743–e24743. 40 indexed citations
14.
15.
Lebouché, Bertrand, Omar Farnós, Joel Singer, et al.. (2020). Impact of extended-release niacin on immune activation in HIV-infected immunological non-responders on effective antiretroviral therapy. SHILAP Revista de lepidopterología. 21(6). 182–190. 2 indexed citations
16.
Arora, Anish, Amélie Quesnel‐Vallée, David Lessard, et al.. (2020). Barriers and facilitators associated with steps of the HIV care cascade for migrants in OECD countries: a systematic mixed studies review protocol. BMJ Open. 10(11). e040646–e040646. 6 indexed citations
18.
Engler, Kim, et al.. (2019). A review of HIV-specific patient-reported measures of perceived barriers to antiretroviral therapy adherence: what themes are they covering?. Journal of Patient-Reported Outcomes. 3(1). 37–37. 8 indexed citations
19.
Lebouché, Bertrand, Kim Engler, Joseph Josy Lévy, et al.. (2013). Minimal interference: A basis for selecting ART for prevention with positives. AIDS Care. 25(10). 1284–1290. 3 indexed citations
20.
Engler, Kim. (2011). On the health and wellbeing of single working women without children : an analysis of scientific and lay discourse. Papyrus : Institutional Repository (Université de Montréal). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026